Related Experiment Video
Updated: Jul 13, 2026

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy
Luigi Moretti1, Eddy S Yang, Kwang W Kim
1Department of Radiation Oncology, Vanderbilt Ingram Cancer Center, Vanderbilt University School of Medicine, 1301 22nd Avenue South, B-902 The Vanderbilt Clinic, Nashville, TN 37232-5671, United States.
Abstract:
Non-apoptotic forms of programmed cell death are targets for novel approaches in anticancer therapy. Indeed, cancer cells often present with mutations in the apoptotic machinery that result in resistance to most anticancer therapies and contribute to a relatively low response rate to therapies based on the use of pro-apoptotic strategies. (Macro-)autophagy can be a highly efficient mode of cell death induction by excessive self-digestion as demonstrated by our experiments that studied the effect of radiation to induce autophagy cell death in apoptosis-deficient cells. Despite current controversies on the possible role of autophagy in the process of carcinogenesis and cancer progression by promoting cell survival, autophagy can be seen as a backup cell death mechanism, when other cell death mechanisms fail. This review will focus on the pathways linking autophagy and cancer that are relevant for target identification and on pharmaceuticals that can be utilized to improve cancer therapy by targeting the autophagic pathway.
Insights
Non-apoptotic programmed cell death, including autophagy, offers novel anticancer therapy strategies. Targeting autophagy can enhance cancer treatment, especially in apoptosis-resistant cancers.
Area of Science:
- Oncology
- Cellular Biology
- Pharmacology
Background:
- Cancer cells frequently exhibit resistance to apoptosis-inducing therapies due to mutations.
- Non-apoptotic programmed cell death pathways are crucial for alternative cancer treatment strategies.
- Autophagy, a cellular self-digestion process, can act as a cell death mechanism when apoptosis is impaired.
Purpose of the Study:
- To review pathways linking autophagy and cancer for novel therapeutic targets.
- To identify pharmaceuticals for enhancing cancer therapy by targeting autophagy.
Main Methods:
- Review of scientific literature on autophagy and cancer.
- Analysis of experimental data on radiation-induced autophagy in apoptosis-deficient cells.
- Identification of potential drug targets within the autophagy pathway.
Main Results:
- Autophagy can induce cell death, particularly in cancer cells with defective apoptosis.
- Radiation can effectively induce autophagy-mediated cell death.
- Autophagy's role in cancer is complex, potentially promoting survival or death.
Conclusions:
- Targeting autophagy presents a promising strategy for overcoming resistance in anticancer therapy.
- Pharmaceuticals modulating autophagy could improve treatment outcomes for various cancers.
- Further research into autophagy-cancer pathways is essential for drug development.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

